Literature DB >> 9743575

Mitochondria in sporadic amyotrophic lateral sclerosis.

R H Swerdlow1, J K Parks, D S Cassarino, P A Trimmer, S W Miller, D J Maguire, J P Sheehan, R S Maguire, G Pattee, V C Juel, L H Phillips, J B Tuttle, J P Bennett, R E Davis, W D Parker.   

Abstract

Mitochondria are abnormal in persons with amyotrophic lateral sclerosis (ALS) for unknown reasons. We explored whether aberration of mitochondrial DNA (mtDNA) could play a role in this by transferring mitochondrial DNA (mtDNA) from ALS subjects to mtDNA-depleted human neuroblastoma cells. Resulting ALS cytoplasmic hybrids (cybrids) exhibited abnormal electron transport chain functioning, increases in free radical scavenging enzyme activities, perturbed calcium homeostasis, and altered mitochondrial ultrastructure. Recapitulation of defects previously observed in ALS subjects and ALS transgenic mice by expression of ALS mtDNA support a pathophysiologic role for mtDNA mutation in some persons with this disease. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743575     DOI: 10.1006/exnr.1998.6866

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  37 in total

Review 1.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

2.  Mitochondrial DNA haplogroups and amyotrophic lateral sclerosis.

Authors:  Patrick F Chinnery; Catherine Mowbray; Hannah Elliot; Joanna L Elson; Hannah Nixon; Judith Hartley; Pamela J Shaw
Journal:  Neurogenetics       Date:  2006-11-03       Impact factor: 2.660

3.  Investigation of the mitochondrial genome in patients with atypical motor neuron disease.

Authors:  Catherine Phoenix; Geoffrey A Taylor; Judith Hartley; Hannah Nixon; Paul G Ince; Pamela J Shaw; Douglass M Turnbull; Robert W Taylor
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Sirtuins as therapeutic targets of ALS.

Authors:  Giulio Maria Pasinetti; Amanda E Bilski; Wei Zhao
Journal:  Cell Res       Date:  2013-07-16       Impact factor: 25.617

Review 5.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

6.  Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.

Authors:  Kambiz N Alavian; Steven I Dworetzky; Laura Bonanni; Ping Zhang; Silvio Sacchetti; Maria A Mariggio; Marco Onofrj; Astrid Thomas; Hongmei Li; Jamie E Mangold; Armando P Signore; Ulrike Demarco; Damon R Demady; Panah Nabili; Emma Lazrove; Peter J S Smith; Valentin K Gribkoff; Elizabeth A Jonas
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

7.  AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro.

Authors:  S G Carriedo; S L Sensi; H Z Yin; J H Weiss
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 8.  Mitochondria in neurodegeneration.

Authors:  E Lezi; Russell H Swerdlow
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 9.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.